- Home
- TMUS vs ABT Comparison
TMUS vs ABT Comparison
Compare TMUS & ABT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TMUS
- ABT
- Stock Information
- Founded
- TMUS 1994
- ABT 1888
- Country
- TMUS United States
- ABT United States
- Employees
- TMUS N/A
- ABT N/A
- Industry
- TMUS Telecommunications Equipment
- ABT Medical/Dental Instruments
- Sector
- TMUS Telecommunications
- ABT Health Care
- Exchange
- TMUS Nasdaq
- ABT Nasdaq
- Market Cap
- TMUS 258.1B
- ABT 231.5B
- IPO Year
- TMUS N/A
- ABT N/A
- Fundamental
- Price
- TMUS $201.96
- ABT $123.73
- Analyst Decision
- TMUS Buy
- ABT Strong Buy
- Analyst Count
- TMUS 17
- ABT 18
- Target Price
- TMUS $264.53
- ABT $146.61
- AVG Volume (30 Days)
- TMUS 5.2M
- ABT 6.3M
- Earning Date
- TMUS 10-23-2025
- ABT 10-15-2025
- Dividend Yield
- TMUS 1.99%
- ABT 1.90%
- EPS Growth
- TMUS 18.54
- ABT 141.97
- EPS
- TMUS 10.38
- ABT 7.96
- Revenue
- TMUS $85,847,000,000.00
- ABT $43,843,000,000.00
- Revenue This Year
- TMUS $10.53
- ABT $7.56
- Revenue Next Year
- TMUS $7.34
- ABT $7.78
- P/E Ratio
- TMUS $19.72
- ABT $15.64
- Revenue Growth
- TMUS 7.30
- ABT 6.37
- 52 Week Low
- TMUS $202.73
- ABT $110.86
- 52 Week High
- TMUS $276.49
- ABT $141.23
- Technical
- Relative Strength Index (RSI)
- TMUS 25.69
- ABT 35.16
- Support Level
- TMUS $202.73
- ABT $122.44
- Resistance Level
- TMUS $207.26
- ABT $126.71
- Average True Range (ATR)
- TMUS 5.45
- ABT 2.09
- MACD
- TMUS -1.48
- ABT -0.20
- Stochastic Oscillator
- TMUS 2.44
- ABT 17.49
About TMUS T-Mobile US Inc.
Deutsche Telekom merged its T-Mobile USA unit with prepaid specialist MetroPCS in 2013, and that firm merged with Sprint in 2020, creating the second-largest wireless carrier in the US. T-Mobile now serves 80 million postpaid and 25 million prepaid phone customers, equal to around 30% of the US retail wireless market. The firm entered the fixed-wireless broadband market aggressively in 2021 and now serves 7 million residential and business customers. In addition, T-Mobile provides wholesale services to resellers.
About ABT Abbott Laboratories
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives approximately 60% of sales outside the United States.